Prophylactic implantable defibrillators for hypertrophic cardiomyopathy: disarray in the era of precision medicine.
From the Papworth Hospital NHS Foundation Trust, Cambridge, United Kingdom; and Department of Biochemistry, University of Cambridge, Cambridge, United Kingdom. aag1000@cam.ac.uk.
Andrew
A
Grace
D002309:Cardiology; D002312:Cardiomyopathy, Hypertrophic / Q000150:complications*; D016757:Death, Sudden, Cardiac / Q000517:prevention & control*; D005260:Female; D006801:Humans; D008297:Male; D017410:Practice Guidelines as Topic / Q000592:standards*; D011322:Primary Prevention / Q000592:standards*; D018570:Risk Assessment / Q000379:methods*; D012955:Societies, Medical
Editorials; cardiac; cardiomyopathy; death; defibrillators; guideline; hypertrophic; implantable; sudden; ventricular fibrillation